Physician
Central River Healthcare Group, PLLC
Central River Healthcare Group, PLLC was paid $2.15M by Medicaid between Jan 2018 and Dec 2024, across 75 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 26% of everything it billed.
33Billing provider infoCENTRAL RIVER HEALTHCARE GROUP, PLLC
AUSTIN, TX 78741
AUSTIN, TX 78741
33aNPI1295813764assigned 11/01/2006
33bProvider typeFamily Medicine Physician
28Total paid$2.15M
24GClaims137,979
24DCodes billed75
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#53 of 1,204
Median peer was paid$31K
This provider vs. median70×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16 | $828.80 | |
| 2019 | 26 | $1K | |
| 2020 | 4,645 | $61K | |
| 2021 | 27,257 | $376K | |
| 2022 | 38,238 | $594K | |
| 2023 | 36,056 | $602K | |
| 2024incomplete | 31,741 | $515K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 10,835 | 8,734 | $551K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.0% | 3,571 | 3,024 | $130K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.9% | 1,593 | 1,506 | $127K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.4% | 1,434 | 1,333 | $115K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 4.6% | 2,737 | 2,192 | $100K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 4.2% | 2,645 | 2,393 | $91K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.0% | 6,452 | 2,980 | $87K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.9% | 4,237 | 3,865 | $85K |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | 3.4% | 818 | 756 | $74K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.2% | 900 | 861 | $70K |
| 99050 | 2.7% | 4,060 | 3,448 | $58K | |
| 99000 | 2.6% | 5,638 | 4,992 | $56K |
63 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 2.3% | 602 | $50K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.3% | 4,736 | $49K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 3,617 | $49K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.2% | 3,527 | $47K |
| 92553 | 2.0% | 1,452 | $44K | |
| 99429 | 1.3% | 925 | $29K | |
| 99215 | Doctor's office visit, returning patient (complex) | 1.2% | 330 | $26K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 397 | $23K |
| 86318 | 1.0% | 1,416 | $22K | |
| 82977 | <1% | 3,708 | $21K | |
| 82150 | <1% | 3,727 | $19K | |
| 84460 | <1% | 3,732 | $16K | |
| 84075 | <1% | 3,713 | $15K | |
| 82310 | <1% | 3,724 | $15K | |
| 82565 | <1% | 3,724 | $15K | |
| 84450 | <1% | 3,696 | $15K | |
| 82040 | <1% | 3,840 | $15K | |
| 82247 | <1% | 3,701 | $15K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,647 | $13K |
| 84550 | <1% | 3,718 | $13K | |
| 84520 | <1% | 3,745 | $12K | |
| 82947 | <1% | 3,755 | $12K | |
| 84155 | <1% | 3,707 | $11K | |
| 86308 | <1% | 2,284 | $9K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 383 | $8K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 314 | $7K |
| 69210 | <1% | 140 | $6K | |
| 97802 | <1% | 2,140 | $5K | |
| 81002 | <1% | 1,485 | $4K | |
| 99383 | <1% | 45 | $4K | |
| 99401 | <1% | 1,986 | $4K | |
| 99382 | <1% | 38 | $3K | |
| 96160 | <1% | 1,461 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,062 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,224 | $2K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 12 | $933.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,933 | $924.10 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 2,576 | $791.56 |
| 90688 | <1% | 1,014 | $647.43 | |
| 81025 | <1% | 85 | $535.02 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 241 | $404.00 |
| 83605 | <1% | 34 | $330.48 | |
| 83655 | <1% | 13 | $146.90 | |
| 82374 | <1% | 34 | $139.40 | |
| 84295 | <1% | 34 | $137.36 | |
| 84132 | <1% | 34 | $136.00 | |
| 36410 | <1% | 29 | $55.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 14 | $16.50 |
| 36415 | Collection of venous blood by venipuncture | 0% | 3,607 | $0.00 |
| 83735 | 0% | 33 | $0.00 | |
| 90651 | 0% | 271 | $0.00 | |
| 36416 | 0% | 59 | $0.00 | |
| 90620 | 0% | 30 | $0.00 | |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | 0% | 12 | $0.00 |
| 82438 | 0% | 33 | $0.00 | |
| 90700 | 0% | 72 | $0.00 | |
| 90734 | 0% | 66 | $0.00 | |
| 90715 | 0% | 33 | $0.00 | |
| 90707 | 0% | 12 | $0.00 | |
| 90713 | 0% | 15 | $0.00 | |
| 84100 | 0% | 33 | $0.00 | |
| 99173 | 0% | 13 | $0.00 | |
| 90649 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTRINH, LOANN (PRESIDENT/MEDICAL DIRECTOR)